-
PDF
- Split View
-
Views
-
Cite
Cite
Nina Vodošek Hojs, Robert Ekart, Sebastjan Bevc, Nejc Piko, Radovan Hojs, MO159
CHA2DS2-VASC SCORE AS A PREDICTOR OF CARDIOVASCULAR MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS, Nephrology Dialysis Transplantation, Volume 36, Issue Supplement_1, May 2021, gfab092.0037, https://doi.org/10.1093/ndt/gfab092.0037 - Share Icon Share
Abstract
Cardiovascular mortality is high in chronic kidney disease (CKD) patients. Recognizing patients with higher cardiovascular risk might help in their treatment. CHA2DS2-VASc score was originally used to predict cerebral infarction in patients with atrial fibrillation (AF). However, it is also useful in predicting outcome in different cardiovascular conditions, independent of the presence of AF. Therefore, the aim of our research was to assess the role of CHA2DS2-VASc score in cardiovascular mortality in CKD patients.
Eighty-seven non-dialysis CKD patients from our outpatient clinic were included. At the time of inclusion, medical history data and standard blood results were collected and CHA2DS2-VASc score was calculated. Patients were followed for assigned time or until their death. Mean follow-up time was 1696.45±564.60 days.
Descriptive statistics of our patients are presented in table 1. During follow-up 11 patients suffered from cardiovascular death. Univariate Cox regression analysis showed that CHA2DS2-VASc score is a significant predictor of cardiovascular mortality (HR: 2.19, CI: 1.42-3.37, p=0.001). In multivariate Cox regression analysis in which CHA2DS2-VASc score, serum creatinine, urinary albumin/creatinine, haemoglobin, high sensitivity CRP and intact PTH were included, CHA2DS2-VASc score was an independent predictor of cardiovascular mortality (HR: 2.04, CI: 1.20-3.45, p=0.008) (table 2).
Descriptive statistics of 87 CKD patients presented as mean±SD or as absolute number of patients with a known condition.
. | CKD patients (N=87) . |
---|---|
Age (years) | 60.29±12.84 |
Sex - male/female | 57/30 |
Arterial hypertension | 85 |
Diabetes | 22 |
Dyslipidaemia | 43 |
Smoking - past or current | 39 |
CHA2DS2-VASc score | 2.49±1.40 |
Serum creatinine (µmol/l) | 260.40±134.69 |
eGFR (ml/min/1.73m2) | 29.50±22.54 |
Urinary albumin/creatinine (mg/g) | 935.75±1426.71 |
Haemoglobin (g/l) | 129.41±18.50 |
High sensitivity CRP (mg/l) | 5.27±9.14 |
Calcium (mmol/l) | 2.23±0.14 |
Phosphate (mmol/l) | 1.23±0.35 |
Intact PTH (pg/ml) | 139.10±110.52 |
. | CKD patients (N=87) . |
---|---|
Age (years) | 60.29±12.84 |
Sex - male/female | 57/30 |
Arterial hypertension | 85 |
Diabetes | 22 |
Dyslipidaemia | 43 |
Smoking - past or current | 39 |
CHA2DS2-VASc score | 2.49±1.40 |
Serum creatinine (µmol/l) | 260.40±134.69 |
eGFR (ml/min/1.73m2) | 29.50±22.54 |
Urinary albumin/creatinine (mg/g) | 935.75±1426.71 |
Haemoglobin (g/l) | 129.41±18.50 |
High sensitivity CRP (mg/l) | 5.27±9.14 |
Calcium (mmol/l) | 2.23±0.14 |
Phosphate (mmol/l) | 1.23±0.35 |
Intact PTH (pg/ml) | 139.10±110.52 |
Descriptive statistics of 87 CKD patients presented as mean±SD or as absolute number of patients with a known condition.
. | CKD patients (N=87) . |
---|---|
Age (years) | 60.29±12.84 |
Sex - male/female | 57/30 |
Arterial hypertension | 85 |
Diabetes | 22 |
Dyslipidaemia | 43 |
Smoking - past or current | 39 |
CHA2DS2-VASc score | 2.49±1.40 |
Serum creatinine (µmol/l) | 260.40±134.69 |
eGFR (ml/min/1.73m2) | 29.50±22.54 |
Urinary albumin/creatinine (mg/g) | 935.75±1426.71 |
Haemoglobin (g/l) | 129.41±18.50 |
High sensitivity CRP (mg/l) | 5.27±9.14 |
Calcium (mmol/l) | 2.23±0.14 |
Phosphate (mmol/l) | 1.23±0.35 |
Intact PTH (pg/ml) | 139.10±110.52 |
. | CKD patients (N=87) . |
---|---|
Age (years) | 60.29±12.84 |
Sex - male/female | 57/30 |
Arterial hypertension | 85 |
Diabetes | 22 |
Dyslipidaemia | 43 |
Smoking - past or current | 39 |
CHA2DS2-VASc score | 2.49±1.40 |
Serum creatinine (µmol/l) | 260.40±134.69 |
eGFR (ml/min/1.73m2) | 29.50±22.54 |
Urinary albumin/creatinine (mg/g) | 935.75±1426.71 |
Haemoglobin (g/l) | 129.41±18.50 |
High sensitivity CRP (mg/l) | 5.27±9.14 |
Calcium (mmol/l) | 2.23±0.14 |
Phosphate (mmol/l) | 1.23±0.35 |
Intact PTH (pg/ml) | 139.10±110.52 |
Multivariate Cox regression analysis of factors related to cardiovascular death in CKD patients.
. | Hazard ratio . | 95% confidence interval . | p . |
---|---|---|---|
CHA2DS2-VASc score | 2.04 | 1.20-3.45 | 0.008 |
Serum creatinine | 1.00 | 0.99-1.01 | 0.384 |
Urinary albumin/creatinine | 1.04 | 0.63-1.71 | 0.891 |
Haemoglobin | 0.95 | 0.90-1.00 | 0.051 |
High sensitivity CRP | 0.90 | 0.74-5.27 | 0.245 |
Intact PTH | 1.00 | 0.99-1.01 | 0.639 |
. | Hazard ratio . | 95% confidence interval . | p . |
---|---|---|---|
CHA2DS2-VASc score | 2.04 | 1.20-3.45 | 0.008 |
Serum creatinine | 1.00 | 0.99-1.01 | 0.384 |
Urinary albumin/creatinine | 1.04 | 0.63-1.71 | 0.891 |
Haemoglobin | 0.95 | 0.90-1.00 | 0.051 |
High sensitivity CRP | 0.90 | 0.74-5.27 | 0.245 |
Intact PTH | 1.00 | 0.99-1.01 | 0.639 |
Multivariate Cox regression analysis of factors related to cardiovascular death in CKD patients.
. | Hazard ratio . | 95% confidence interval . | p . |
---|---|---|---|
CHA2DS2-VASc score | 2.04 | 1.20-3.45 | 0.008 |
Serum creatinine | 1.00 | 0.99-1.01 | 0.384 |
Urinary albumin/creatinine | 1.04 | 0.63-1.71 | 0.891 |
Haemoglobin | 0.95 | 0.90-1.00 | 0.051 |
High sensitivity CRP | 0.90 | 0.74-5.27 | 0.245 |
Intact PTH | 1.00 | 0.99-1.01 | 0.639 |
. | Hazard ratio . | 95% confidence interval . | p . |
---|---|---|---|
CHA2DS2-VASc score | 2.04 | 1.20-3.45 | 0.008 |
Serum creatinine | 1.00 | 0.99-1.01 | 0.384 |
Urinary albumin/creatinine | 1.04 | 0.63-1.71 | 0.891 |
Haemoglobin | 0.95 | 0.90-1.00 | 0.051 |
High sensitivity CRP | 0.90 | 0.74-5.27 | 0.245 |
Intact PTH | 1.00 | 0.99-1.01 | 0.639 |
CHA2DS2-VASc score is a simple and quick way to identify cardiovascular risk in CKD patients.
- atrial fibrillation
- dyslipidemias
- smoking
- hypertension
- hemodialysis
- cardiovascular diseases
- diabetes mellitus
- heart disease risk factors
- cerebral infarction
- albumins
- kidney failure, chronic
- diabetes mellitus, type 2
- calcium
- creatinine
- hemoglobin
- ambulatory care facilities
- follow-up
- phosphates
- urinary tract
- dialysis procedure
- medical history
- creatinine tests, serum
- cox proportional hazards models
- cardiovascular death
- descriptive statistics
- cha2ds2-vasc score
Comments